Business Wire (May 10, 2013)
Quote & Headlines
Market Currents
StockTalk
Today
5d
1m
3m
1y
5y
10y
52wk high:
52wk low:
EPS:
PE:
Div Rate:
Yield:
Market Cap:
Volume:
HEADLINES:
ALL
|
PRO
|
FOCUS
|
RELATED
|
TRANSCRIPTS
|
NEWS & PR
-
-
Business Wire (Apr 12, 2013)
-
Business Wire (Mar 15, 2013)
-
Business Wire (Mar 4, 2013)
-
Business Wire (Mar 1, 2013)
-
Business Wire (Feb 26, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Nov 8, 2012)
To learn more about Seeking Alpha Pro, click here.
-
BioSante Pharma Reaquires ElestrinMike Havrilla • Mon, Oct 6, 2008
-
BioSante Pharma Announces Its Re-Acquisition of ElestrinMike Havrilla • Sun, Aug 10, 2008
-
What This News Means For Healthcare StocksTimeless Wealth • Tue, Jun 19, 2012
There are no Transcripts on BPAX.
-
Business Wire (May 10, 2013)
-
Business Wire (Apr 12, 2013)
-
Business Wire (Mar 15, 2013)
-
Business Wire (Mar 4, 2013)
-
Business Wire (Mar 1, 2013)
-
Business Wire (Feb 26, 2013)
-
Business Wire (Feb 19, 2013)
-
Business Wire (Nov 8, 2012)
-
Business Wire (Oct 8, 2012)
-
at MarketWatch.com (Oct 4, 2012)
-
at MarketWatch.com (Oct 4, 2012)
-
Business Wire (Oct 4, 2012)
-
Business Wire (Aug 20, 2012)
-
Business Wire (Aug 17, 2012)
-
Business Wire (Aug 1, 2012)
BPAX vs. ETF Alternatives
Company Description
We are a specialty pharmaceutical company focused on developing products for female sexual health, menopause, contraception and male hypogonadism. Our primary products are gel formulations of testosterone and estradiol. We also are engaged in the development of our proprietary calcium... More











